BackNewAmsterdam Pharma Company NV Overview

NewAmsterdam Pharma Company NV Total Liabilities

Track NewAmsterdam Pharma Company NV's total liabilities ($67M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$67.42M
↑ 64.24% YoYΔ $26.37M vs prior year quarter

Peer average

Loading

NewAmsterdam Pharma Company NV Total Liabilities History

Loading

NewAmsterdam Pharma Company NV vs. peers: Total Liabilities Comparison

Loading

NewAmsterdam Pharma Company NV Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

NewAmsterdam Pharma Company NV (NAMS) FAQ

As of the most recent data (March 2026), NAMS shows a total liabilities of $67M. That compares with $41M in the prior-year period — up 64.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NAMS's total liabilities is now $67M (was $41M) — a 64.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether NewAmsterdam Pharma Company NV is outperforming or lagging.

Tracking NAMS's total liabilities over time shows whether NewAmsterdam Pharma Company NV is scaling, shrinking, or reshaping that part of the business. The current reading is $67M That compares with $41M in the prior-year period — up 64.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has NewAmsterdam Pharma Company NV's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $67M) with ownership activity and broader fundamentals.